These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1668432)

  • 1. [Endovascular surgery and the validation of immunocorrection in patients with liver cirrhosis complicated by portal hypertension].
    Karimov ShI; Kim VF; Iunusov IR
    Vestn Khir Im I I Grek; 1991 May; 146(5):26-8. PubMed ID: 1668432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complex treatment of complications of liver cirrhosis].
    Borisov AE; Levin LA; Borisova NA; Verkhovskiĭ VS; Mosiagin VB; Faĭnzi'lberg SI
    Vestn Khir Im I I Grek; 1989 Jun; 142(6):21-5. PubMed ID: 2815466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular embolization of the hepatolienal vessels in the treatment of portal hypertension.
    Karimov ShI; Borovskiĭ SP; Rakhmanov SU; Atakhanov DA
    Angiol Sosud Khir; 2003; 9(2):40-6. PubMed ID: 12811373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Splenectomy in patients with liver cirrhosis complicated by portal hypertension].
    Patsiora MD; Kniazeva GD; Ershov IuA; Morozov VA; Chumachenko PV
    Khirurgiia (Mosk); 1983 Jul; (7):60-3. PubMed ID: 6620913
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term results of the embolization of the hepatic and splenic arteries in liver cirrhosis].
    Granov AM; Ryzhkov VK; Tarazov PG
    Khirurgiia (Mosk); 1991 Nov; (11):84-8. PubMed ID: 1779561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin].
    Chuvirov GN; Markova TP
    Ter Arkh; 1986; 58(9):67-70. PubMed ID: 3787495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
    Ianiushina VV
    Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The results of endovascular embolization of the gastric veins in patients with portal hypertension complicated by esophagogastric hemorrhage].
    Prokubovskiĭ VI; Cherkasov VA
    Vestn Khir Im I I Grek; 1993; 151(7-12):16-9. PubMed ID: 7975008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
    Sarkisian SV
    Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of splenic artery embolization in treating complicated liver cirrhosis].
    Kalita NIa; Bulanov KI; Nikishin LF; Kondratiuk VA; Egorova ON
    Klin Khir; 1995; (9-10):5-9. PubMed ID: 8697221
    [No Abstract]   [Full Text] [Related]  

  • 14. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laparoscopic splenectomy and pericardial devascularization for treatment of portal hypertension due to liver cirrhosis].
    Hong DF; Zheng XY; Peng SY; Gao M; Wu JG; Cao Q
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):820-2. PubMed ID: 17565864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The characteristics of the surgical procedure in treating subcompensated portal hypertension in liver cirrhosis].
    Nazyrov FG; Vakhidov AV; Deviatov AV; Akilov KhA; Mansurov AA
    Vestn Khir Im I I Grek; 1992; 149(11-12):318-22. PubMed ID: 8594788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T-activin in the treatment of patients with recurrent aphthous stomatitis].
    Terekhova NV; Khazanova VV; Zemskaia EA; Bykova IA; Filonenko OF; Kosorukova NIa; Rabinovich IM
    Stomatologiia (Mosk); 1991; (2):35-7. PubMed ID: 1853375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of taktivin in patients with viral myocarditis and dilated cardiomyopathy].
    Kipshidze NN; Dzhaparidze MM; Dzidziguri LM; Rachvelishvili NB; Dateshidze MN; Demetrashvili MF
    Ter Arkh; 1990; 62(9):116-8. PubMed ID: 2177920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of immunological indices for assessing the severity of the course of periodontitis and treatment efficacy].
    Bazhanov NN; Ter-Asaturov GP; Kassin VIu; Ivaniushko TP; Arion VIa; Simonova AV
    Stomatologiia (Mosk); 1996; 75(1):15-8. PubMed ID: 8658566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Partial splenic embolization as treatment for portal hypertension].
    Iijima T; Kojima T; Koitabashi H; Shiojima M; Osumi M; Nakano G; Nagamachi Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Nov; 47(11):1405-12. PubMed ID: 3447091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.